- Home
- BLLN vs PCVX Comparison
BLLN vs PCVX Comparison
Compare BLLN & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLLN | PCVX |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 6.0B |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BLLN | PCVX |
|---|---|---|
| Price | $88.91 | $48.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $137.83 | $101.67 |
| AVG Volume (30 Days) | 209.0K | ★ 1.5M |
| Earning Date | 12-09-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $254,136,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 254.30 | N/A |
| 52 Week Low | $88.00 | $27.66 |
| 52 Week High | $138.70 | $93.77 |
Technical Indicators
Market Signals| Indicator | BLLN | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 59.46 |
| Support Level | N/A | $42.40 |
| Resistance Level | N/A | $48.65 |
| Average True Range (ATR) | 0.00 | 1.75 |
| MACD | 0.00 | 0.16 |
| Stochastic Oscillator | 0.00 | 92.34 |
Price Performance
Historical ComparisonAbout BLLN BillionToOne Inc.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.